000 04410nam a2200457 i 4500
999 _c121590
_d121590
001 121590
003 ES-MaUEC
005 20230102114140.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 200715s2020 gw a o |||| 0|eng d
020 _a9783030504946
024 7 _a10.1007/978-3-030-50494-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRJ560
_b2020 EB
245 0 0 _aPediatric Pharmacotherapy
_cedited by Wieland Kiess, Matthias Schwab, Johannes van den Anker
250 _aFirst edition
264 1 _aCham
_bImprint: Springer
_c2020
264 1 _aCham
_bSpringer International Publishing
_c2020
300 _a1 recurso en línea (VIII, 538 páginas)
_b1 ilustración
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aHandbook of Experimental Pharmacology
_x0171-2004
_v261
490 0 _aBiomedical and Life Sciences (SpringerNature-11642)
490 0 _aBiomedical and Life Sciences (R0) (SpringerNature-43708)
505 0 _aAnti-epileptic drugs in pediatrics -- Current and new therapies for Duchenne Muscular Dystrophy -- Lysosomal diseases -- Mitochondriopathies -- Endocrinology thyroid, pituitary, growth stimulant, growth reduction -- Bone disease - bisphosphonates -- Diabetes type 1 and 3 (insulin; sulfonylurea; others) -- Diabetes type 2 (metformin etc.) -- Dermatology - part 1 urticaria, atopic dermatitis -- Dermatology part 2, ichtyosis, psoriasis -- Cardiovascular part 1- catcholamines, inotropic -- Cardiovascular part 2 - antiarhythmica, anti hypertensives -- Nephrology - dialysis -- How to use drugs in obese children and adolescents -- Haematology - CSFs, erythropoietin -- Antiretroviral/HIV -- Clinical pharmacology and pharmacometrics to better understand physiological changes during pregnancy and neonatal life -- Antihelminth treatment -- Inflammatory bowel disease -- Constipation; laxatives -- Psychiatric diseases in children and adolescents -- Oncology - cell reducing agents part 1, part 2, part 3 -- Immunosuppressants - organ transplantation -- Bone marrow/stem cell transplantation -- Narcotic sparing approaches and the shift towards paracetamol in neonatal intensive care -- Disorders of puberty: pharmacotherapeutic strategies for management.
520 _aThis volume provides readers with the most updated scientific information on the efficacy and safety of medicines for children and adolescents. The book enriches the understanding of pediatric pharmacotherapy for health professionals, regulatory agencies, pharmaceutical companies and learned societies. It contains important information on the pharmacodynamics and pharmacokinetics of drugs. It summarizes the latest investigations on the effects of pharmacological treatments in relation to and dependent on age, gender, fat mass and disease status. Therefore and importantly, this volume reviews the latest data on how pharmacotherapy has to be adjusted and personalized in regards to stages of development and during the pediatric lifespan from neonate through adolescence. In addition, the topic of rare diseases and special challenges for pharmacotherapy will be included and will provide readers with the necessary knowledge to handle complex diseases and treatment strategies especially in relation to pharmacotherapy of rare and orphan diseases.
988 _aSpringer_Biomedlife_03082020
650 7 _2embne
_aFarmacología pediátrica
_9673518
700 1 _aKiess, Wieland
_eeditor literario
_4http://id.loc.gov/vocabulary/relators/edt
_0http://id.loc.gov/authorities/names/nr2001011719
_1http://viaf.org/viaf/57219034
_9675391
700 1 _aSchwab, Matthias
_eeditor literario
_4http://id.loc.gov/vocabulary/relators/edt
_0http://id.loc.gov/authorities/names/no2009048810
_1http://viaf.org/viaf/77385699
_9675392
700 1 _aVan den Anker, Johannes
_eeditor literario
_4http://id.loc.gov/vocabulary/relators/edt
_9675393
776 0 8 _iPrinted edition:
_z9783030504939
776 0 8 _iPrinted edition:
_z9783030504953
776 0 8 _iPrinted edition:
_z9783030504960
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-50494-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b08/2020
_dz
_ek
_zSI